## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 1.3% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($75.90)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Ventas Inc. stock underperforms Monday when compared to competitors despite daily gains**
- Source: MarketWatch | 20251215T165400 | Somewhat-Bearish | Relevance: 100%
- Ventas Inc. (VTR) shares rose 1.09% to $78.71 on Monday, marking their second consecutive day of gains. However, this performance underperformed the broader market, as the S&P 500 Index (SPX) fell 0.16% and the Dow Jones Industrial Average (DJIA) fell 0.09% on the same day.

**2. Hudson Bay Capital Management LP Makes New Investment in Ventas, Inc. $VTR**
- Source: MarketBeat | 20251215T105904 | Somewhat-Bullish | Relevance: 100%
- Hudson Bay Capital Management LP has made a new investment in Ventas, Inc. ($VTR), purchasing 278,193 shares valued at approximately $17.57 million. This investment comes as Ventas demonstrates strong financials, beating EPS estimates and showing significant revenue growth. Despite a high payout ratio for its dividend, the company maintains a "Moderate Buy" consensus analyst rating.

**3. Ventas (VTR) Valuation Check After Strong Q3 and Accelerated Senior Housing Expansion**
- Source: Simply Wall Street | 20251215T172952 | Somewhat-Bullish | Relevance: 100%
- Ventas (VTR) recently affirmed a quarterly dividend of $0.48 per share, following a strong third quarter and impressive stock performance. The company's valuation narrative suggests it is 8.1% undervalued with a fair value of $84.70, despite market ratios flashing a caution sign with a higher price-to-sales ratio compared to peers. Ventas' strategy involves active portfolio management and strategic acquisitions to drive revenue and FFO per share growth.

**4. Ventas (VTR) Valuation Check After Strong Q3 and Accelerated Senior Housing Expansion**
- Source: Simply Wall Street | 20251215T170843 | Somewhat-Bullish | Relevance: 99%
- Ventas (VTR) recently affirmed a quarterly dividend of $0.48 per share, continuing its strong income story alongside impressive stock performance. The company's valuation is being assessed after its robust third quarter, with one narrative suggesting it's 8.1% undervalued compared to its fair value of $84.70, driven by active portfolio management and strategic acquisitions. However, market ratios flash a caution sign, as its price-to-sales ratio is higher than the broader North American Health Care REITs group.

**5. Welltower (WELL): Reassessing Valuation After a Strong 3-Month and 1-Year Share Price Rally**
- Source: Simply Wall Street | 20251217T153026 | Neutral | Relevance: 63%
- Welltower (WELL) has seen its share price rally significantly, up 15% in three months and 50% in the last year, prompting a reassessment of its valuation. While a narrative fair value suggests the stock is undervalued at $207.38 due to aggressive growth assumptions and acquisitions like Amica Senior Living, another view highlights that the market is already paying a steep price, with a P/E ratio of 136x earnings. Investors need to consider if the current premium reflects sustainable growth or if the stock is vulnerable to market corrections from stretched expectations.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $85 | $70 | +21% |
| 2025-11-25 | Wells Fargo | $88 | $80 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 17 ($4.24M) |
| Sells | 13 ($23.19M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Heavy insider selling: $23M sold (13 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +6.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Analyst sentiment positive (2 raises, avg +16%). Insider selling cluster ($23.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.1B |
| Beta | 0.79 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 139.6 |
| Current P/E | 292.2 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -4.9% to 1.3% (+6.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.7pp (needs >4.0% for momentum thesis). MRS_5 at 2.8% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.15x) but short-term weakness (below SMA20). RSI neutral at 55. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.27% (CS: 41) | Neutral |
| RSI_14 | 55.0 | Neutral |
| MACD Histogram | -0.48 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 1.047x | Above |
| vs SMA200 | 1.147x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $78.90
- **Stop Loss:** $75.90 (3.8% risk)
- **Target:** $81.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 360
- **Position Value:** $28,404.00
- **Portfolio %:** 28.40%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*